We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Yield10 Bioscience Inc (YTEN) USD0.01

Sell:$2.37 Buy:$2.46 Change: $0.1 (4.39%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
Change: $0.1 (4.39%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
Change: $0.1 (4.39%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Yield10 Bioscience, Inc. is an agricultural bioscience company. The Company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low-carbon sustainable seed products. The Company focuses on petroleum replacement markets, in which it is developing Camelina oil for use as a biofuel feedstock and polyhydroxyalkanoates (PHA) bioplastics produced in Camelina seed for use as a biodegradable bioplastic; and food and nutrition markets, in which it is developing omega-3 (DHA+EPA) oils produced in Camelina seed for aquaculture, nutraceuticals and protein meal for animal feed markets. It is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits that form improved elite Camelina varieties for the biofuel market. The Company's new seed product traits include the PHA bioplastic trait developed by the Company and the omega-3 (DHA+EPA) oil traits.

Contact details

19 Presidential Way Ste 201
United States
+1 (617) 5831700

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$11.03 million
Shares in issue:
4.90 million
United States
US dollar

Key personnel

  • Oliver Peoples
    President, Chief Executive Officer, Director
  • Charles Haaser
    Chief Accounting Officer, Vice President - Finance, Treasurer
  • Lynne Brum
    Vice President - Planning and Communications
  • Kristi Snell
    Chief Science Officer, Vice President - Research
  • Darren Greenfield
    Senior Director - Seed Operations
  • Tichafa Munyikwa
    Director of Regulatory Affairs
  • Nicholas Renegar
    Director of Business Analytics and Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.